scholarly journals Rate of fall of blood glucose and physiological responses of counterregulatory hormones, clinical symptoms and cognitive function to hypoglycaemia in Type I diabetes mellitus in the postprandial state

Diabetologia ◽  
2003 ◽  
Vol 46 (1) ◽  
pp. 53-64 ◽  
Author(s):  
C. Fanelli ◽  
S. Pampanelli ◽  
F. Porcellati ◽  
L. Bartocci ◽  
L. Scionti ◽  
...  
Diabetes Care ◽  
1993 ◽  
Vol 16 (Supplement_3) ◽  
pp. 71-89 ◽  
Author(s):  
G. B. Bolli ◽  
G. Perriello ◽  
C. G. Fanelli ◽  
P. De Feo

BMJ ◽  
1986 ◽  
Vol 292 (6521) ◽  
pp. 647-650 ◽  
Author(s):  
S Pramming ◽  
B Thorsteinsson ◽  
A Theilgaard ◽  
E M Pinner ◽  
C Binder

1988 ◽  
Vol 117 (3) ◽  
pp. 315-319 ◽  
Author(s):  
P. Pietschmann ◽  
G. Schernthaner

Abstract. Increased GH levels in Type I diabetes mellitus have been implicated in the pathogenesis of metabolic complications such as the so-called dawn phenomenon. GH secretion is under control of cholinergic mechanisms. In 21 Type I diabetic patients the effect of oral administration of the anticholinergic drug pirenzepine in addition to intensive insulin therapy on GH and blood glucose levels was studied. At 21.30, 08.00 and 12.00 h, all patients received in random order 50 mg of pirenzepine or placebo po. Blood for determination of GH, blood glucose, cortisol and Cpeptide levels were obtained at 3-h intervals. Serum levels of plasma glucose and GH were significantly lower under pirenzepine than under placebo (P < 0.05 and P < 0.01, respectively). Serum levels of cortisol, free insulin and C-peptide were comparable on the test and the control day. Our data indicate that in Type I diabetes mellitus the anticholinergic drug pirenzepine is effective in decreasing both GH and blood glucose levels.


Sign in / Sign up

Export Citation Format

Share Document